ProRx recalls

ProRx has 14 recalls on record with the FDA and USDA, the earliest in 2024 and the latest reported on 5 Nov 2025. 14 are still ongoing. 7 were reported in the last 12 months. The most frequent reason is sterility.

Total recalls14since 2024
Last 12 months7reported
Class I00% of total
Ongoing14latest 5 Nov 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 14 100%Class III 0 0%

Why prorx is recalled

Product types

By year

Ongoing prorx recalls

14 active

All prorx recalls, newest first

14 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IISemaglutide Injection, 5 mg/ (2.5 mg/mL) Multidose Vial recalledProRxSterilityTX, UT
DrugCLASS IISemaglutide Injection (2.5 mg/mL) Multidose Vial recalled by ProRxProRxSterilityTX, UT
DrugCLASS IITirzepatide Injection, 27 mg/ (9 mg/mL) Multidose Vial recalled by ProRxProRxSterilityTX, UT
DrugCLASS IISemaglutide Injection, 8mg/ (2.5 mg/mL) Multidose Vial recalled by ProRxProRxSterilityTX, UT
DrugCLASS IISemaglutide Injection, 2.5mg/ (2.5 mg/mL) Multidose Vial recalledProRxSterilityTX, UT
DrugCLASS IISemaglutide Injection, 6mg/ (2.5 mg/mL) Multidose Vial recalled by ProRxProRxSterilityTX, UT
DrugCLASS IISemaglutide Injection, 10 mg/ (2.5 mg/mL) Multidose Vial recalledProRxSterilityTX, UT
DrugCLASS IISemaglutide 10mg/ (2.5mg/mL) Multiple Dose Vial recalled by ProRxProRxSterilityNationwide
DrugCLASS IITirzepatide 20 mg/ (10/mg/mL) recalled by ProRxProRxSterilityNationwide
DrugCLASS IITirzepatide 60 mg/ (20/mg/mL) recalled by ProRxProRxSterilityNationwide
DrugCLASS IISemaglutide 5mg/ (2.5mg/mL) recalled by ProRxProRxSterilityNationwide
DrugCLASS IISemaglutide / Cyanocobalamin Injection recalled by ProRxProRxSterilityNationwide
DrugCLASS IISemaglutide (2.5mg/mL), Compounded RX Product recalled by ProRxProRxSterilityNationwide
DrugCLASS IITirzepatide (10 mg/mL) and 20 mg/mL Multidose SC Injection recalledProRxSterilityNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.